TECH Q2 Earnings & Revenues Beat Estimates, Operating Margin Up
Bio-Techne tops Q2 EPS and revenue estimates as operating margin jumps 244 bps, even with flat organic sales and a slight year-over-year revenue dip.
Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Techne (TECH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Techne (TECH) Beats Q2 Earnings and Revenue Estimates
Techne (TECH) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.42 per share a year ago.
Biotech firm Bio-Techne beats quarterly estimates on strength in key unit
Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development.
Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?
TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
Bio-Techne Corporation (TECH) Presents at 53rd Annual Nasdaq Investor Conference Transcript
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (TECH) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
Bio-Techne Corporation (TECH) Presents at Evercore 8th Annual Healthcare Conference Transcript
CMB.TECH NV (CMBT) Q3 2025 Earnings Call Transcript
CMB.TECH NV ( CMBT ) Q3 2025 Earnings Call November 26, 2025 8:00 AM EST Company Participants Alexander Saverys - CEO & Member of Management Board Ludovic Saverys - CFO & Member of Management Board Enya Derkinderen - Brand Manager Conference Call Participants Frode Morkedal - Clarksons Platou Securities AS, Research Division Eirik Haavaldsen - Pareto Securities AS, Research Division Kristof Samoy - KBC Securities NV, Research Division Climent Molins - Value Investor's Edge Kristoffer Skeie - Arctic Securities AS, Research Division Axel Styrman - Kepler Cheuvreux, Research Division Quirijn Mulder - ING Groep N.V., Research Division Presentation Alexander Saverys CEO & Member of Management Board Good afternoon and welcome to the Cmb.Tech's Earnings Conference Call for the Third Quarter of 2025.
Bio-Techne Corporation (TECH) Presents at Jefferies London Healthcare Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) Jefferies London Healthcare Conference 2025 November 20, 2025 7:30 AM EST Company Participants James Hippel - Executive VP of Finance & CFO Conference Call Participants Tycho Peterson Tycho Peterson Presentation Tycho Peterson Okay. Great. We're going to kick it off.
Bio-Techne Corporation (TECH) Presents at Stephens Annual Investment Conference 2025 Transcript
Bio-Techne Corporation ( TECH ) Stephens Annual Investment Conference 2025 November 18, 2025 9:00 AM EST Company Participants James Hippel - Executive VP of Finance & CFO William Geist - President of Protein Sciences Segment Conference Call Participants Steven Etoch - Stephens Inc., Research Division Presentation Steven Etoch Stephens Inc., Research Division [Audio Gap] Is intended to be more of a fireside chat, so I'll stop along the way and poll for any questions. So feel free to chime in as needed.
